Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.11 (
CD10
)
9,792
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The main form of gastrin in antral mucosa, the amidated heptadecapeptide
G17
, is generated from an inactive precursor, progastrin, by steps involving
endopeptidase
cleavage and amidation. Gastrin cells are normally inhibited by gastric acid and in this study we have examined how suppression of acid by treatment with omeprazole for 6-8 weeks influences gastrin production in patients with oesophagitis. Plasma concentrations of total amidated gastrins in the fasting state increased from 18 to 43 pmol l-1; assays specific for
G17
-immunoreactivity indicated that the plasma concentrations of this form increased from 6 to 12 pmol l-1. In endoscopic biopsies of antral mucosa there was no change with omeprazole treatment in the concentrations of total amidated gastrins, or their immediate precursors, the Gly-extended gastrins. However, assays using an antibody that reacts with progastrin, together with size exclusion chromatography, indicated that tissue progastrin concentration increased 6-fold. The data suggest a modest net increase in gastrin production with omeprazole-treatment; because the ratio of tissue concentrations of total amidated gastrins to Gly-extended gastrins did not change, it would seem that the amidating capacity of the gastrin cell was maintained. However, the increase in progastrin concentrations suggests a relative failure of the initial steps of post-translational processing, and consequently that in certain circumstances
endopeptidase
cleavage of progastrin may be rate limiting.
...
PMID:Increased tissue concentrations of the gastrin precursor in patients treated with omeprazole. 145 68
The degradation of human sulphated heptadecapeptide gastrin (G17s) by human
endopeptidase 24.11
was studied in vitro. The products of degradation were characterized by HPLC, region-specific gastrin radioimmunoassay and amino acid analysis. The enzyme cleaved G17s at four sites, Trp4-Leu5, Ala11-Tyr12, Gly13-Trp14 and Asp16-Phe17. The patterns of fragments produced when sulphated and unsulphated G17s are hydrolysed by
endopeptidase 24.11
indicate that the enzyme cleaves both substrates at the same four bonds. However, the sulphated
G17
was 3-times less rapidly degraded than the unsulphated
G17
(G17ns). In contrast, the rate of cleavage of the octapeptide cholecystokinin (CCK8) was faster when the peptide was sulphated. The kinetic data of
endopeptidase 24.11
indicated similar Km values for sulphated or unsulphated gastrin and CCK; sulphated CCK8 exhibited a 2-fold higher kcat/Km value compared to unsulphated CCK8, whereas G17s exhibited a 2-fold lower kcat/Km value compared to G17ns. The results indicate that the presence of a sulphate group causes a marked reduction in the rate of hydrolysis of gastrin by
endopeptidase 24.11
, whereas sulphation enhances cholecystokinin degradation by the same enzyme. They also suggest that
endopeptidase 24.11
may be responsible for the difference in metabolism of sulphated and unsulphated
G17
, previously observed in human circulation.
...
PMID:Degradation of human gastrin and CCK by endopeptidase 24.11: differential behaviour of the sulphated and unsulphated peptides. 273 61
An antiserum, L221, has been developed that is specific for the C-terminal region of the N-terminal tridecapeptide (i.e., 1-13) fragment of the acid-stimulating hormone,
G17
. In contrast to N-terminal
G17
antisera previously used to estimate 1-13
G17
, L221 does not cross-react with other N-terminal gastrin fragments or with C-terminal extensions of
G17
. Using L221 in conjunction with conventional gastrin antisera, and reversed-phase HPLC, it has been possible to identify in addition to 1-13
G17
a further, formerly unrecognised gastrin fragment, 1-11
G17
, in stomach extracts. The production of 1-13
G17
, 1-11
G17
and other gastrin forms such as the biologically active hexapeptide G6 which is known to occur naturally cannot be explained by tryptic cleavage of progastrin. Instead, their biosynthesis could be explained by the actions of an enzyme with an
endopeptidase 24.11
-like specificity. In porcine antrum, unsulphated and sulphated
G17
are present in similar amounts, but unsulphated 1-13
G17
was about twice as abundant as sulphate 1-13
G17
. This is consistent with previous in vitro findings that
endopeptidase 24.11
has a higher affinity for the Ala-11-Tyr-12 and Gly-13-Trp-14 bonds in unsulphated
G17
, than in sulphated
G17
. The results suggest a novel albeit minor, processing pathway for gastrin biosynthesis in pig antrum involving an enzyme resembling
endopeptidase 24.11
.
...
PMID:A novel gastrin-processing pathway in mammalian antrum. 336 33